Lee K Y, Park J A, Chung E, Lee Y H, Kim S I, Lee S K
College of Pharmacy, Seoul National University, Kwanak-Gu, South Korea.
Cancer Lett. 1996 Dec 20;110(1-2):193-200. doi: 10.1016/s0304-3835(96)04502-8.
The mechanism of action by which ginsenoside-Rh2 (G-Rh2) suppresses the proliferation of SK-HEP-1 cells is reported. The results from flow cytometric analyses show that G-Rh2 arrested the cell cycle at the G1/S transition phase. The cyclin E-dependent kinase activity which had been immunoprecipitated with cyclin E-specific antibody was down-regulated in the cells in response to G-Rh2. The IC50 value required to down-regulate the kinase activity by 50% was approximately 0.75 microM. Immunoblotting analyses show that G-Rh2 selectively induced the expression of p27kip1 in a dose-dependent manner whereas it had no effect on the levels of cyclin E, cdk2, and p21WAF1. In addition, our data show that G-Rh2 reduced the protein levels of cdc25A at doses higher than 10 microM. Collectively, these data suggest that ginsenoside-Rh2 arrests the cell cycle at the G1/S transition phase by selectively inducing protein expression of p27Kip1 and, as a consequence, down-regulating cyclin E-dependent kinase activity.
据报道了人参皂苷-Rh2(G-Rh2)抑制SK-HEP-1细胞增殖的作用机制。流式细胞术分析结果显示,G-Rh2使细胞周期阻滞在G1/S转换期。用细胞周期蛋白E特异性抗体免疫沉淀的细胞周期蛋白E依赖性激酶活性在G-Rh2作用下的细胞中下调。使激酶活性下调50%所需的IC50值约为0.75微摩尔。免疫印迹分析表明,G-Rh2以剂量依赖性方式选择性诱导p27kip1的表达,而对细胞周期蛋白E、细胞周期蛋白依赖性激酶2(cdk2)和p21WAF1的水平没有影响。此外,我们的数据表明,G-Rh2在高于10微摩尔的剂量下降低了细胞分裂周期蛋白25A(cdc25A)的蛋白水平。总体而言,这些数据表明人参皂苷-Rh2通过选择性诱导p27Kip1的蛋白表达,进而下调细胞周期蛋白E依赖性激酶活性,使细胞周期阻滞在G1/S转换期。